Stay updated on SB414 PK, PD, Safety in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SB414 PK, PD, Safety in Psoriasis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A centralized Locations section now lists Idaho, Texas, and Virginia as study sites, replacing the prior state-specific location subsections, and the page revision is updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T08:26:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The top of the page now shows Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:30:53.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Deleted the government-funding notice about potential data delays and limited response times. The page no longer displays the operating-status disclaimer.
    Difference
    0.4%
    Check dated 2025-11-17T19:54:28.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page appears to retain core study details (conditions, eligibility criteria, interventions, outcomes, locations, and dates) with only cosmetic layout changes between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:22:54.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    5%
    Check dated 2025-10-06T04:21:18.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added version label (v3.1.0); removed multiple drug-safety and regulatory sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, etc.). The net effect is a narrowing of content rather than expansion.
    Difference
    0.6%
    Check dated 2025-09-28T23:39:00.000Z thumbnail image

Stay in the know with updates to SB414 PK, PD, Safety in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.